Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Critical Comparison: ARM (NASDAQ:ARM) and indie Semiconductor (NASDAQ:INDI)
ARM (NASDAQ:ARM – Get Free Report) and indie Semiconductor (NASDAQ:INDI – Get Free Report) are both computer and technology companies,...
World News in Brief: Arrivals surge in South Sudan, the rise of digital media, Haiti crisis update
UNHCR, the UN refugee agency, has issued an alert after a surge in the number of displaced people fleeing war-torn...
How to Navigate Bankruptcy as Your Last Resort
By Javier Simon Debt can be a soul-crushing burden pushing you through serious mental, emotional, and even physical damage. But...
Environmental Waste International (CVE:EWS) Reaches New 52-Week Low – Should You Sell?
Environmental Waste International Inc. (CVE:EWS – Get Free Report) reached a new 52-week low during trading on Tuesday . The...
UN continues response to crises in Gaza and Lebanon
UN agencies continue their response to the humanitarian crises in Gaza and Lebanon, as access challenges, food shortages and reconstruction...
Aberdeen International (TSE:AAB) Stock Price Down 18.2% – What’s Next?
Aberdeen International Inc. (TSE:AAB – Get Free Report)’s stock price fell 18.2% during trading on Tuesday . The stock traded...